Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants
Recruitment status was: Recruiting
RATIONALE: Developing a personalized screening plan may be more effective than usual care in increasing the number of healthy participants who regularly undergo screening for colorectal cancer.
PURPOSE: This randomized phase III trial is studying personalized screening plans to see how well they work compared with usual care in increasing colorectal cancer screening in healthy participants.
Other: medical chart review
Other: survey administration
Procedure: fecal occult blood test
Procedure: screening colonoscopy
|Study Design:||Allocation: Randomized
Masking: Single Blind
Primary Purpose: Health Services Research
|Official Title:||Tailored Navigation in CRC Screening|
- Screening utilization over the 6-month observation period [ Designated as safety issue: No ]
- Screening preference [ Designated as safety issue: No ]
- Perceived salience and coherence and self-efficacy related to colorectal cancer (CRC) screening [ Designated as safety issue: No ]
- Number and length of contacts with each participant and the type of communication during those contacts [ Designated as safety issue: No ]
- Identification of predictors of CRC screening use and screening preference [ Designated as safety issue: No ]
|Study Start Date:||January 2007|
|Estimated Primary Completion Date:||December 2010 (Final data collection date for primary outcome measure)|
- To compare the impact of tailored intervention vs standard intervention vs usual care on patient utilization of colorectal cancer (CRC) screening.
- To compare the impact of these interventions on CRC screening preference.
- To compare the impact of these interventions on patient perceptions about CRC screening.
OUTLINE: This is a multicenter study. Participants are stratified by practice and study wave and blocking. Participants are randomized to 1 of 3 arms.
- Arm I (usual care): Participants receive usual care in accordance with their normal patterns of interaction with study practices.
- Arm II (standard intervention [SI]): A generic screening invitation letter, a colorectal cancer (CRC) screening informational booklet, stool blood testing (SBT) cards, and instructions for arranging a colonoscopy screening appointment are mailed to participants on day 15. On day 45, a reminder letter is mailed to participants who have not completed SBT or undergone a screening colonoscopy.
- Arm III (tailored navigation intervention [TNI]): A test-specific screening invitation letter, a CRC screening informational booklet, and additional test-specific materials (i.e., instructions for arranging a colonoscopy screening appointment or SBT cards) are mailed to participants on day 15. On day 30, a patient navigator contacts participants by telephone who have not completed SBT or undergone a screening colonoscopy. The patient navigator re-assesses screening test-specific decision stage; addresses CRC screening barriers; develops a personalized CRC screening plan to move the participant towards screening use (i.e., explains the steps in completing the SBT or scheduling a colonoscopy appointment); and facilitates screening plan implementation. On day 45, a reminder letter is mailed to participants who were contacted by the navigator.
Participants in all arms complete a survey at baseline and then at 6 months. Medical records for each participant are reviewed at 6 months.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00617071
|United States, Pennsylvania|
|Kimmel Cancer Center at Thomas Jefferson University - Philadelphia|
|Philadelphia, Pennsylvania, United States, 19107-5541|
|Study Chair:||Ronald Myers, PhD||Jefferson Medical College of Thomas Jefferson University|